Pharmaceutical News

InSilicoTrials releases two new state-of-the-art simulation tools for oncology 

Milan, InSilicoTrials has been innovating the healthcare sector for some years now, helping pharmaceutical companies reduce the time and cost of drug development using modeling & simulation. The release of two new products for oncology that have no equals on the market – PCa GnRH Agonists Simulator and CTx NeutroSim – is going to accelerate the …

InSilicoTrials releases two new state-of-the-art simulation tools for oncology  Read More »

Pharmapack Europe 2021 Award Winners Announced

Paris, Pharmapack Europe (#PharmapackEU) announce the winners of the 2021 Pharmapack Awards and, due to the exceptional quality of this year’s entries, seven winners have been chosen across both the ‘Exhibitor Innovation’ and ‘Health Product’ awards. The Exhibitor Innovation awards recognise four winners plus one highly commended product. EVEON was given the ‘routes of administration’ innovation award for their …

Pharmapack Europe 2021 Award Winners Announced Read More »

Edison Oncology and Apollomics Announce Treatment of First Patient by EO1001 (APL-122) in a Phase I/IIa Clinical Trial

MENLO PARK, Calif., FOSTER CITY, Calif. and HANGZHOU, China, Edison Oncology Holding Corp. (‘Edison Oncology’), a company established to develop new therapies targeting the fight against cancer, and Apollomics Inc. (‘Apollomics’), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination oncology therapies, reported that the first patient was dosed with …

Edison Oncology and Apollomics Announce Treatment of First Patient by EO1001 (APL-122) in a Phase I/IIa Clinical Trial Read More »

CPhI Worldwide: 9-11 November 2021 in Milan, Italy

“In a year when literally hundreds of our exhibitors have contributed to overcoming COVID, the greatest healthcare challenge of recent times, we are delighted to be welcoming back the pharma community. CPhI Worldwide is an essential conduit in helping pharma supply chains work, partners meet, empowering the industry with learning. But this year, more than …

CPhI Worldwide: 9-11 November 2021 in Milan, Italy Read More »

A*STAR and Local SME Work with Vaccination Centres to Deploy Automated Systems for Filling Syringes

SINGAPORE; The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers AVID was designed …

A*STAR and Local SME Work with Vaccination Centres to Deploy Automated Systems for Filling Syringes Read More »

I Holland Celebrates 75 Years of Excellence

As the longest established tablet compression tooling manufacturer in the world, I Holland is celebrating its 75th anniversary. The company has reached this remarkable milestone due to their commitment to research, development and investment which has established the company as the pre-eminent supplier of punches and dies to producers of tablets across the globe. As a true British …

I Holland Celebrates 75 Years of Excellence Read More »

Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin

SHANGHAI, Hua Medicine (“Hua Medicine”; SEHK: 2552) today announced that at the 6th China BioMed Innovation and Investment Conference held September 25-27 in Suzhou, China (the “CBIIC”), Professor Jianhua MA, Director of the Department of Endocrinology, Nanjing First Hospital, Standing Member of the Chinese Diabetes Society, as one of the principal researchers, presented the results …

Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin Read More »

Syntegon to showcase new laboratory and small batch solutions for solid and liquid pharmaceuticals

New York/USA, At Interphex 2021 in New York, Syntegon (formerly Bosch Packaging Technology) presents new solutions for lab-scale and small batch filling of solid and liquid pharmaceuticals. “The need for smaller quantities of highly potent drugs is rising continuously. We have put these solutions in the focus of our current development activities and are proud …

Syntegon to showcase new laboratory and small batch solutions for solid and liquid pharmaceuticals Read More »

Clinical investigation shows Herb-Pharma’s ViroStop spray effective in reducing impact of Covid-19

A recent clinical study has shown that the ViroStop anti-viral spray from Swiss company, Herb-Pharma is effective in reducing the impact of Covid-19 for patients with mild to moderate symptoms. The key benefits were a 60% reduction in viral shedding after using the treatment and a reduction in the severity of clinical respiratory symptoms. The study supports …

Clinical investigation shows Herb-Pharma’s ViroStop spray effective in reducing impact of Covid-19 Read More »

Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials

Nantes, France, Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of viral vaccines BSL2/BSL3, oncolytic viruses and viral vectors, today announces the next phase in its partnership with FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases. Naobios will initiate the GMP …

Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials Read More »

Portuguese initiative wins FIP Pharmacy Practice Improvement Award

The Hague, A freephone service created by a pharmacy COVID-19 “crisis cabinet” to maintain care and help ensure safety of citizens and pharmacy teams following a declaration of a state of emergency is the winner of the International Pharmaceutical Federation (FIP) Pharmacy Practice Improvement Award 2021. The award to the National Association of Pharmacies (ANF), Portugal, …

Portuguese initiative wins FIP Pharmacy Practice Improvement Award Read More »

Pharmapack Report 2021

Paris, Ahead of the first Pharmapack Europe to be held in nearly 18-months, Informa has released the results of its global drug delivery and packaging survey, with the USA once again leading ‘drug delivery and device innovation’, but lagging behind all major European nations on sustainability. Pharmapack Europe, which will be held at Paris Expo, Porte de Versailles, 13-14 …

Pharmapack Report 2021 Read More »

Catalent Signs Commercial Supply Agreement with Phathom

SOMERSET, N.J. Catalent, the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies;  and consumer health products, today announced that it had signed a commercial supply agreement with Phathom Pharmaceuticals, a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, for its lead compound, vonoprazan, which …

Catalent Signs Commercial Supply Agreement with Phathom Read More »

Legend Capital Led a New Round of Investment of Etana

HONG KONG, Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM). This round of funds will be used to further strengthen the company’s production, registration, clinical and commercialization capabilities, promote the company’s extensive …

Legend Capital Led a New Round of Investment of Etana Read More »

Sterling Pharma Solutions Establishes Centre of Excellence in Continuous Flow Chemistry

Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced the completion of the initial phase of investment at its site in Dudley, UK to create the company’s centre of excellence for research into commercial applications of continuous flow chemistry. Announcement of the investment follows the appointment of Professor Ian R. Baxendale to …

Sterling Pharma Solutions Establishes Centre of Excellence in Continuous Flow Chemistry Read More »

Provepharm Life Solutions raises €120 million

Marseille, France, Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, today announces a €120 million ($142.3M) strategic funding. Tikehau Capital will provide the funds and joins the group’s pool of banking investors, including Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence and Bpifrance. This new …

Provepharm Life Solutions raises €120 million Read More »

Pharmacists must be mobilised to mitigate health impacts of air pollution

The Hague, Pharmacists must be allowed to do more to manage respiratory conditions in communities if the urgent need to address the harmful effects of air pollution on health is to be met, the International Pharmaceutical Federation (FIP) said today. The expansion of pharmacists’ roles in mitigating the health threats of air pollution is among several …

Pharmacists must be mobilised to mitigate health impacts of air pollution Read More »

Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain

Singapore, Local family cord blood bank Cryoviva Singapore (https://cryoviva.com.sg) is continuing with its rapid geographic growth plans with an entry into the Bahrain market. This latest new market entry closely follows Cryoviva establishing a footprint in Dubai to serve couples in the UAE that are on the family way. “It fills the entire Cryoviva team …

Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain Read More »

TANAKA Contributes to Ambix Life Science Fund

TOKYO, TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which is a subsidiary of TANAKA Holdings Co., Ltd. and operates the TANAKA Precious Metals manufacturing business, announced today that TANAKA made an equity contribution to Ambix Life Science Fund I, L.P., a medical device venture fund managed by Ambix …

TANAKA Contributes to Ambix Life Science Fund Read More »

DoKaSch Temperature Solutions opens new service station in India

Frankfurt/Hyderabad, DoKaSch Temperature Solutions has opened a new service station in India. It is located at GMR Hyderabad Air Cargo terminal. Strategically, the Hyderabad Airport location is a very important network station for the global supply of lifesaving medicines given Hyderabad’s status as a major pharma production and export hub. With the new location in India, …

DoKaSch Temperature Solutions opens new service station in India Read More »

Lumiio streamlines data collection, changing the face of global health collaboration

CALGARY, AB: Reliable, consistent, and applicable data is a key feature of well-executed research and the development of new treatments. For some diseases and disorders, possible study participants are spread out across the world, preventing effective research and slowing down the process of improving quality of life for the people who need them most.Lumiio is determined …

Lumiio streamlines data collection, changing the face of global health collaboration Read More »

New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2

SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL are pleased toannounce a new collaboration to develop an inhaled dry powder formulation of SF2523 for the treatmentof pulmonary fibrosis, lung cancer and SARS-CoV-2 related illnesses. SignalRx SF2523 is a novel, small molecule dual PI3K-BRD4 inhibitor with a synergistic action on twopathways associated with the development …

New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2 Read More »

Agilex Biolabs Partners with Endpoints News for Webinar on Rapid Vaccine Development in Australia

ADELAIDE- Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif. Agilex Biolabs’ Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) Hons; …

Agilex Biolabs Partners with Endpoints News for Webinar on Rapid Vaccine Development in Australia Read More »

Azelis publishes its 2020 sustainability report

SINGAPORE- Azelis, a leading innovative service provider in the specialty chemicals and food ingredients industry, is proud to publish its second sustainability report which covers the 2020 group-wide sustainability performance.  Highlights & rationale– The report showcases Azelis’ environmental, social, and governance (ESG) commitments and reinforces its ambitions to become the world-leading provider of sustainable solutions …

Azelis publishes its 2020 sustainability report Read More »

FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Endometrial Carcinoma

Immunotherapy and Tyrosine Kinase Inhibitor Combination Approved for the Treatment of Patients With Advanced Endometrial Carcinoma Study Results Demonstrated Statistically Significant Improvements in Overall Survival, Progression-Free Survival and Overall Response Rate, Helping to Address a Significant Unmet Need in Advanced Endometrial Carcinoma TOKYO and KENILWORTH, N.J. – (JCN Newswire) – Eisai Co., Ltd. and Merck …

FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Endometrial Carcinoma Read More »

CPhI Awards 2021 Open for Entries in Incredible Year for Pharma Innovation

On 9 November 2021, the 18th Annual CPhI Pharma Awards will take place in Milan, Italy at the Stella Polare Convention Centre. The CPhI Pharma Awards celebrate innovators and thought leaders breaking new ground in the pharma and biopharma industries, and their commitment to advancing new approaches, processes and technologies. Held as part of CPhI Worldwide …

CPhI Awards 2021 Open for Entries in Incredible Year for Pharma Innovation Read More »

Vectura Signs Pre-Clinical Development Agreement with Incannex to Advance IHL-216A for the Treatment of Traumatic Brain Injury

Vectura Group plc, an industry leading inhalation CDMO, today announced it has signed an agreement with Incannex Healthcare Limited, an Australian cannabinoid medicines development company, to provide pre-clinical development services for IHL-216A, Incannex’s proprietary inhaled drug product for the treatment of traumatic brain injury (TBI). Under the terms of the agreement, Vectura will undertake formulation screening …

Vectura Signs Pre-Clinical Development Agreement with Incannex to Advance IHL-216A for the Treatment of Traumatic Brain Injury Read More »

Alfa Laval makes ‘full-single-use’ cell harvesting possible amid industry challenges

As growing strain on pharmaceutical technology necessitates more efficient practice, Alfa Laval has launched the CultureOne™, the industry’s first premium separator system for single-use cell culture processing. According to Bioplan Associates, single-use bioprocessing technologies now dominate the pre-commercial manufacturing space. However, Alfa Laval states many companies have not been able to make the transition to …

Alfa Laval makes ‘full-single-use’ cell harvesting possible amid industry challenges Read More »

Kurita Expands Presence in North America

Completes Acquisition of Keytech Water Management of Canada Minneapolis, MN: Kurita Water Industries (Kurita) (Headquarters, Tokyo, Japan), a leading global provider of water treatment solutions, today announced the completion of its acquisition of Keytech Water Management (“Keytech”) through its North American subsidiaries in a stock purchase deal. Keytech, headquartered in Kitchener, Ontario, will operate as …

Kurita Expands Presence in North America Read More »

Telstar addresses the latest trends in aseptic process solutions at Achema Pulse 2021

Terrassa (Barcelona): Telstar will be exhibiting the latest developments in aseptic technology for pharmaceutical production and integrated turnkey engineering & construction services for process facilities at Achema Pulse 2021. The company will be present at the digital flagship event of the global process industries during the whole of June and will be live during 15-16th June. …

Telstar addresses the latest trends in aseptic process solutions at Achema Pulse 2021 Read More »

Pacira BioSciences, Inc. partners with Ashfield Engage to deliver European commercial infrastructure

Ashfield Engage, part of UDG Healthcare plc, today announced that it has been selected by US-based Pacira BioSciences, Inc. to provide strategic commercialization services for its non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to develop a commercial strategy and deliver outsourced operations in numerous European countries, including the …

Pacira BioSciences, Inc. partners with Ashfield Engage to deliver European commercial infrastructure Read More »

ASPA and Messe Frankfurt India to unite experts to discuss ideas for securing the pharmaceutical supply chain

Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from the pharmaceutical segment for a live panel discussion on 11 June …

ASPA and Messe Frankfurt India to unite experts to discuss ideas for securing the pharmaceutical supply chain Read More »

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications. RIM Bio’s Changzhou, China facility is Avantor’s …

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China Read More »

SIRIO’s Nutra-Innovation Team tackles global surge in demand for novel mood and stress health formulations

SIRIO Group’s global Nutra-Innovation Team is rapidly intensifying efforts to create new formulations in different delivery formats for mood and stress relief. The team’s focus follows a year of global lockdowns in which consumers faced significant challenges. This has led to a rise in demand for products that enhance personal health and wellness – mind and body – …

SIRIO’s Nutra-Innovation Team tackles global surge in demand for novel mood and stress health formulations Read More »

CPhI Worldwide and Pharmapack Europe given the all-clear by host country governments

The second week of CPhI Discover is open amid news that both the Italian and French governments have confirmed they will allow trade shows to resume – providing formal confirmation for both CPhI Worldwide and Pharmapack Europe. The last year has seen pharma evolve its approach to meeting new partners and existing customers, with wider pools of …

CPhI Worldwide and Pharmapack Europe given the all-clear by host country governments Read More »

Experts state contract services sector the big winner of pandemic at CPhI Discover

Contract services experts at this week’s CPhI Discover – (17-28th May, 2021) – the largest ever online pharma event featuring content in the opening week and networking in week two – point to pandemic contracts delivering a significant boon to the CDMO sector, but forewarn of exacerbated shortages for viral vector manufacturing. In a dedicated session three experts – Peter …

Experts state contract services sector the big winner of pandemic at CPhI Discover Read More »

Ashfield Engage acquires Nuvera to enhance Patient Solutions offering

Nuvera are experts in optimizing the design and build of seamless patient and HCP treatment experiences. This expertise will enhance Ashfield Engage’s Patient Solutions capabilities and create an end-to-end strategic offering across their client’s product lifecycles. Following the acquisition, Ashfield Engage and Nuvera will offer integrated specialist support and services including late-phase clinical trial experience, …

Ashfield Engage acquires Nuvera to enhance Patient Solutions offering Read More »

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

Terrassa (Barcelona). Azbil Telstar announces the appointment of Rashedi Hassan as a Sales & Marketing Manager of the subsidiary of the company in Dhaka, Bangladesh. From 14th February 2021, Rashedi Hassan focuses his responsibility on developing extensive marketing and sales plan to strengthen the Telstar brand position in the local pharmaceutical market and to promote …

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh Read More »

QED Advocates New British Standard for Soil Sampling

Industry specialists working on contaminated land are being urged to use the new British Standard BS 10176 for soil sampling. BS 10176 was introduced in August 2020 but tests using old methods, which do not conform to the new standard, are still being accepted by regulators and assessors, which has led to concerns that its use …

QED Advocates New British Standard for Soil Sampling Read More »

I Holland Present their Latest Tablet Tooling Developments to a Virtual Audience at ACHEMA Pulse

I Holland, the world’s best-known manufacturer of tablet punches and dies for the pharmaceutical and nutraceutical industries, has announced it will be exhibiting some of it most innovative products at ACHEMA Pulse from 15-19 June, including the new die table segment cleaning equipment. The interactive platform will showcase the company’s extensive portfolio of precision tablet tooling solutions …

I Holland Present their Latest Tablet Tooling Developments to a Virtual Audience at ACHEMA Pulse Read More »

Vaccine Passports in NHS app unethical if they don’t allow date custodianship say FarmaTrust

FarmaTrust, the UK-based global medical supply chain data management provider – has warned that the UK is heading very rapidly down the wrong direction with vaccine passports. The Government last week announced its intention to use the NHS app to provide proof of COVID vaccination status – yet both these solutions are not utilising innovative new …

Vaccine Passports in NHS app unethical if they don’t allow date custodianship say FarmaTrust Read More »

Perigord releases most powerful GLAMS yet – GLAMS 5.0

Perigord announces the release of GLAMS 5.0, the latest update to its industry-leading AMS platform. Developed to the specific needs of the Life Science industry, this latest release boasts an expanded suite of both new and improved features, as well as greatly improved performance. GLAMS 5’s new deep search capabilities break down potential impediments to …

Perigord releases most powerful GLAMS yet – GLAMS 5.0 Read More »

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. Avance Clinical is accredited as a gene technology CRO under the Office of the Gene Technology …

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand Read More »

AavantiBio and Catalent Announce Partnership to Support Development and Manufacturing of Gene Therapies for Rare Genetic Diseases

AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a partnership to support the development and manufacturing of AavantiBio’s gene therapies, …

AavantiBio and Catalent Announce Partnership to Support Development and Manufacturing of Gene Therapies for Rare Genetic Diseases Read More »

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey[i] predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next five years, governments and companies will gradually look to reduce complexity and increase regional self-reliance. Highlighting this …

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth Read More »

CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted

Tokyo 27th April 2021: CPhI Japan, the first large pharma event to trade in 2021, played host to 7214 attendees at the exhibition and a further 7204 virtual users from across the globe.  The event, a key marker for the strength of the regional industry, has rebounded quickly with some 216 exhibitors searching for pharma partners. In …

CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted Read More »

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields

Scivita Medical Technology Co., Ltd. (“Scivita Medical”) announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with contribution from Matrix …

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields Read More »

ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers

 ATMPS Ltd, a leader in blockchain-based “vein to vein” cell orchestration platforms for advanced therapies, and Ori Biotech, an innovator in cell and gene therapy (CGT) manufacturing platforms, today announce a global collaboration to create seamless integration between their respective data platforms to support the development of Advanced Therapies. The non-exclusive partnership will result in the integration …

ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers Read More »

BENEO presents galenIQ for highly flowable and stable sachet powders

Sachets are a popular pharmaceutical and nutraceutical packaging format for consumers and manufacturers alike. To ensure accurate dosage and administration, the powders used in these delivery systems require excellent flowability. BENEO’s filler-binder galenIQ™ 721 meets this demand and helps formulators to develop more convenient dosage forms.  In the pharmaceutical and nutraceutical industries, sachets or stickpacks …

BENEO presents galenIQ for highly flowable and stable sachet powders Read More »

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product

The German pharmaceutical company Dr. August Wolff GmbH & Co. KG  Arzneimittel Arzneimittel (“Dr. Wolff”) and the Spanish pharmaceutical company Cantabria Labs  (“Cantabria Labs”) concluded a strategic partnership on March 12th 2021 by entering into an  exclusive licensing agreement for a newly developed medicinal product for the treatment of  hyperhidrosis. Under the terms of the …

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product Read More »

Catalent Biologics Completes Madison Facility Expansion to Double Clinical and Commercial Drug Substance Capacity

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, Wisconsin, and has now commenced work on customer programs. The expansion has increased …

Catalent Biologics Completes Madison Facility Expansion to Double Clinical and Commercial Drug Substance Capacity Read More »

CPhI Discover: connecting global pharma & pre-qualifying partners ahead of in person events

Informa Markets is launching an annual dedicated online platform for pharma in May (17-28th), CPhI Discover – designed to encourage suppliers and customers to source, meet and discover – providing the industry with a new synergistic offering to sit alongside CPhI’s portfolio of in person events. In the last year, the pharma industry has adapted its approach to meeting new partners …

CPhI Discover: connecting global pharma & pre-qualifying partners ahead of in person events Read More »

Azelis releases ‘Action 2025’, confirming sustainability as a key driver in growth strategy

Azelis, an innovation service provider, is excited to release its sustainability strategy, ‘Action 2025’, reinforcing its commitment to become the world-leading provider of sustainable solutions and services in the specialty chemicals and food ingredients distribution industry. Through its sustainability program and strategy, Azelis wants to turn the sustainability aspirations of its principals and customers into …

Azelis releases ‘Action 2025’, confirming sustainability as a key driver in growth strategy Read More »

Two-month long CPhI Japan Connect to meet demand for pharma partnering in Japan

The Japanese pharmaceutical market is preparing for renewed international growth and partnering. In response, CPhI Japan has opened a two-month long virtual event to meet demand from international pharma. Informa introduced CPhI Japan Connect – a new virtual platform for global professionals looking to grow pharma business in Japan – specifically to help its international audiences continue …

Two-month long CPhI Japan Connect to meet demand for pharma partnering in Japan Read More »

Takeover of Spanish manufacturer STE Tecpharm, S. L. – Romaco expands processing business

With the acquisition of the Spanish manufacturer STE Tecpharm, S. L., Romaco strengthens its position as a turnkey supplier of processing technologies. In particular, Tecpharm’s patented drum coaters will complement Romaco Innojet’s granulation and fluid bed technologies. On 18 March 2021, Romaco Holding GmbH announced the purchase of the Spanish manufacturer of processing technology STE …

Takeover of Spanish manufacturer STE Tecpharm, S. L. – Romaco expands processing business Read More »

Takeover of Spanish manufacturer STE Tecpharm, S. L. – Romaco expands processing business

With the acquisition of the Spanish manufacturer STE Tecpharm, S. L., Romaco strengthens its position as a turnkey supplier of processing technologies. In particular, Tecpharm’s patented drum coaters will complement Romaco Innojet’s granulation and fluid bed technologies. On 18 March 2021, Romaco Holding GmbH announced the purchase of the Spanish manufacturer of processing technology STE …

Takeover of Spanish manufacturer STE Tecpharm, S. L. – Romaco expands processing business Read More »

DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders

Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons and glia cells. DZNE is a world-leading interdisciplinary public research organization constituted with ten research …

DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders Read More »

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company seeking to discover and develop innovative …

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19 Read More »

CPhI Report forecasts explosion of contract services growth due to surging INDs and 75 FDA approvals by 2025

A post-pandemic pharma report from CPhI predicts the next few years will deliver strong growth in pharma innovation, with oncology and rare diseases potentially the biggest beneficiaries of positive covid legacies – including accelerated development timelines, remote trials and new technologies in genetic and target screening. The report anticipates breakthroughs in multi-modal disease therapies within five years, …

CPhI Report forecasts explosion of contract services growth due to surging INDs and 75 FDA approvals by 2025 Read More »

Syngenta and Botanical Solution Inc. (BSI) team up for a new botanical-based biofungicde rollout !

Davis, CA: Botanical Solution Inc. (BSI) and Syngenta, two companies which are closely aligned in their commitment to innovation and sustainability in agriculture, announce that they have reached an agreement to commercialize BSI’s first product in Peru and Mexico. The two companies have already commercialized successfully the product in Chile under the trade name BotristopÒ. This biofungicide …

Syngenta and Botanical Solution Inc. (BSI) team up for a new botanical-based biofungicde rollout ! Read More »

I Holland Announces a New Leadership Team

I Holland, leaders in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets, has announced a series of appointments to form a new senior management team to lead the company moving forward. The new Board of Directors consists of six highly-experienced team members many of which remain from the previous management team. David …

I Holland Announces a New Leadership Team Read More »

New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong

Eisai Co., Ltd. announced that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has obtained approval for the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. This approval is the first approval for DAYVIGO in Asia …

New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong Read More »

Novartis Piqray(R) – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval

 Novartis announced the Health Sciences Authority (HSA) has approved* Piqray®, an α-specific class I phosphatidylinositol-3-kinase (PIK3CA) inhibitor, for the treatment of postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2-) negative, advanced breast cancer with a PIK3CA mutation in combination with fulvestrant after disease progression following an endocrine-based regimen. …

Novartis Piqray(R) – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval Read More »

New Sales Directors at Romaco in Cologne, Bologna and Karlsruhe

Borja Guerra has been appointed new Sales & Service Director of Romaco Kilian in Cologne. The Romaco facilities in Bologna and Karlsruhe likewise have new Sales Directors: Massimiliano Cesarini and Ralph Augenstein. Romaco Kilian GmbH in Cologne has acquired a new Sales & Service Director. As of February 2021, Borja Guerra is responsible not only …

New Sales Directors at Romaco in Cologne, Bologna and Karlsruhe Read More »

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site

SOMERSET, N.J. and GOSSELIES, BELGIUM — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based in Gosselies, Belgium, today announced that they …

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site Read More »

Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery Platform

Maculus Therapeutix, a preclinical-stage biopharmaceutical company which has developed a SINGLE injection delivery platform for diseases such as wet AMD (Age-related Macular Degeneration) and DME (Diabetic Macular Edema) instead of the standard 8-12 monthly injections, is pleased to welcome Privity FZ LLE as a partner and advisor for upcoming fundraising activities. Maculus plans to raise …

Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery Platform Read More »

QS-21, the ‘Gold Standard’ of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO & Investor Conference

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16.   BSI is well- positioned to become the industry’s most reliable and cost-effective supplier of GMP quality QS-21 …

QS-21, the ‘Gold Standard’ of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO & Investor Conference Read More »

MOVIANTO -DENNIS SPAMER, new Board Member of Movianto GERMANY

The Walden Group is pleased to announce the appointment of Dennis Spamer (38) as member of the Board authorized to sign as statutory director of the company. Together with Thomas Creuzberger, who has been managing Movianto Germany since more than 20 years and Stéphane Baudry, founder and CEO of the Walden Group, Spamer shall push …

MOVIANTO -DENNIS SPAMER, new Board Member of Movianto GERMANY Read More »

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company’s track record as a premiere CDO service provider in the global market. In late 2018, National OncoVenture (NOV), a government-funded virtual oncology drug development program in …

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA Read More »

I Holland to Deliver a Free Tooling Maintenance Webinar Series

Ensuring punches and dies are kept in optimum condition is essential to produce high quality tablets. As the demand for pharmaceutical tablets increases, the importance for proficient tool maintenance becomes even more important.  To help companies understand the processes involved, I Holland, leaders in the manufacture of tablet tooling, will launch a free seven month …

I Holland to Deliver a Free Tooling Maintenance Webinar Series Read More »

Inria and InSilicoTrials partner up on a European project leveraging simulation for cardiac devices and drugs

Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide  insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is particularly difficult in the case of cardiovascular disease, which remains the …

Inria and InSilicoTrials partner up on a European project leveraging simulation for cardiac devices and drugs Read More »

Botanical Solution Inc. (BSI) Secures $3.3 Million in Funding with Second Round Planned for Spring 2021

Davis, CA: Botanical Solution Inc. (BSI), innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured $3.3 million in a seed round of funding, and is planning another round of funding for Spring 2021. The Spring 2021 Round of funding will boost BSI’s proven ability to discover and develop novel botanical products that …

Botanical Solution Inc. (BSI) Secures $3.3 Million in Funding with Second Round Planned for Spring 2021 Read More »

COVID-19 winter lockdowns & national restrictions drive demand for ‘body and mind’ formulations say SIRIO Europe

Manufacturers seeking CDMOs that can quickly develop complex formulations offering both body and mind benefits  SIRIO Europe (Ayanda) – the European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO) and member of SIRIO Group – forecasts a winter surge in requests from nutra brands for new ‘dual benefit’ mood enhancing formulations as a result of COVID-19 measures. The …

COVID-19 winter lockdowns & national restrictions drive demand for ‘body and mind’ formulations say SIRIO Europe Read More »

Telstar strengthens its activity in Bangladesh and relocates its office in Dhaka

Terrassa (Barcelona) 2020. The Telstar subsidiary in Dhaka, Bangladesh, has relocated to a new installation reacting to the ongoing growth of demand for Life Sciences service & product solutions in the region. Under the leadership of Parvez Hashim, Country General Manager, Telstar’s office has consolidated a professional and specialized service in Asia’s pharmaceutical market in …

Telstar strengthens its activity in Bangladesh and relocates its office in Dhaka Read More »

CO2 Safety Monitors for Dry Ice Vaccination

Ormond Beach, FL – CO2Meter, Inc. has partnered with a national pharmacy chain to keep their customers and employees safe from the potential hazardous effects for CO2 exposure from the dry ice that is keeping the COVID-19 vaccines cold. A national pharmacy chain contacted CO2Meter on December 1st asking about devices to detect the release …

CO2 Safety Monitors for Dry Ice Vaccination Read More »

Vectura signs agreement to support the development of VR588 to treat asthma

Chippenham, UK: Vectura Group plc, an industry leading inhalation CDMO, today announces that it has signed a global out licence and development agreement with Kinaset Therapeutics Inc. for the development and commercialisation of VR588, a preclinical novel inhaled pan-JAK inhibitor for the prevention and treatment of severe asthma. Pan-JAK inhibitors have been developed and tested …

Vectura signs agreement to support the development of VR588 to treat asthma Read More »

Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021

The new report looks ahead to a post-pandemic 2021 with pharma manufacturing capacity and payment structures shifting as new sourcing strategies emerge Amsterdam:  A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration in the White House and a return to dual supply chain strategies. The report …

Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021 Read More »

Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO™ (pralsetinib)

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it had entered into a commercial supply agreement with Blueprint Medicines following FDA approval of GAVRETO™ (pralsetinib). Developed by Blueprint Medicines, GAVRETO is a new therapy indicated for …

Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO™ (pralsetinib) Read More »

UCB taps Medisafe in development of digital companion to support patient engagement

Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its antiepileptic medications, with greater capabilities to expand across additional brands. The digital companions streamline support for patients to access financial assistance, patient diaries, and doctor discussion guides throughout their treatment journey. UCB …

UCB taps Medisafe in development of digital companion to support patient engagement Read More »

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December 2020), with a physical exhibition running alongside Virtual Expo Connect (18 November – 18 December 2020)for international audiences unable to attend. The physical exhibition will be held at the SNIEC (Shanghai New International Expo Center), with some 3,000 exhibitors present across three …

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event Read More »

Cognitive function boosted in MCI patients, with new ketogenic drink

New clinical research conducted by the University of Sherbrooke, Canada, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, has established people with Mild Cognitive Impairment (MCI) experienced significant improvement in cognitive function when consuming a specialized ketogenic drink (BrainXpert Energy Complex) twice a day for six months. Affecting 15-20% of people aged 65+, MCI …

Cognitive function boosted in MCI patients, with new ketogenic drink Read More »

CPhI Worldwide to return in 2021: Milan venue to play host to global pharma

2021 will bring global pharma community back together in person to drive business growth CPhI Worldwide (31 August – 2 September 2021) will be held next year in Milan (Fiera Milano) for the first time in over a decade – following its postponement in 2020. The event returns at an apt moment, as the pharma industry in …

CPhI Worldwide to return in 2021: Milan venue to play host to global pharma Read More »

COVID-19 biologics will put huge pressure on large-scale bioprocessing networks

Tightening of bio-manufacturing capacity expected to occur after 2024, whilst Europe forecast to equal North America in total capacity Amsterdam:  The third part of the 2020 CPhI Annual Report – released during the second week of the CPhI Festival of Pharma (5-16 October, 2020) – predicts, that if approved, COVID vaccines and therapeutics will cause an impending biomanufacturing capacity …

COVID-19 biologics will put huge pressure on large-scale bioprocessing networks Read More »

Romaco implements new sustainability strategy

Romaco has appointed a Sustainability Officer and defined goals for the company’s climate-friendly development. Not only is the manufacturer seeking to enable more sustainable production by its customers; Romaco is also keen to improve its own carbon footprint. The Romaco Group has a new central corporate objective: sustainability. To enable climate protection measures to be …

Romaco implements new sustainability strategy Read More »

Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™

Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the market release of SeptiCyte® RAPID on Idylla™ as a CE-marked IVD test. SeptiCyte® RAPID is a host-response test that distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and provides actionable results in about one …

Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™ Read More »

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events

Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival of Pharma (05 – 16 October 2020) – the largest ever virtual pharma event. The pharma schedule includes one further event in 2020: CPhI China, 16-18 December (hybrid event, combining “live” in-person with “virtual”). In …

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events Read More »

Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay

Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that it has received a EUR 1.2 million grant from VLAIO, the Flanders organization for Innovation & Entrepreneurship, for the development of the highly innovative GeneFusion Assay on its easy, rapid molecular and fully automated diagnostics platform Idylla™. …

Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay Read More »

Italy and India the only pharma economies to improve score in 2020 according to the CPhI Pharma Index

Ahead of the CPhI Festival of Pharma (5-16 October, 2020) – global pharma’s largest ever virtual gathering – the CPhI Pharma Index shows only Italy and India have improved their score in 2020, with the majority of industry executives looking for new supply chain partners.  The Index – an aggregated confidence score across the five …

Italy and India the only pharma economies to improve score in 2020 according to the CPhI Pharma Index Read More »

NanoViricides Nominates a Novel Candidate for COVID-19 Treatment

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that it has nominated a clinical drug candidate for the treatment of COVID-19, thus further advancing its COVID-19 program closer to human clinical trials. The Company has accelerated its drug …

NanoViricides Nominates a Novel Candidate for COVID-19 Treatment Read More »

Royal Society of Chemistry’s journal archives now available to companies for Text and Data Mining

The Royal Society of Chemistry has launched its new Text and Data Mining (TDM) solution, making its full collection of research journals available to companies for AI and machine learning applications.  With the volume of published research available growing hourly, access to the RSC’s collection in machine-readable format offers companies the opportunity to extract, pinpoint …

Royal Society of Chemistry’s journal archives now available to companies for Text and Data Mining Read More »

The first mobile processing machine for pilot scale applications – VENTILUS® Pilot by Romaco Innojet

Romaco Innojet has just developed the first mobile processing machine for pilot scale applications. The VENTILUS® Pilot represents an all-in-one solution both for laboratories and for manufacturers of small batch sizes. The system design with only one spray nozzle simplifies scale-up processes. Romaco Innojet has just launched the first mobile processing machine in the market …

The first mobile processing machine for pilot scale applications – VENTILUS® Pilot by Romaco Innojet Read More »

Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology

Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Ingenza has been working closely with researchers at Oxford University and the UK CPI, Wilton, since the start of the outbreak, and the collaboration is …

Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology Read More »

QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma

QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable …

QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma Read More »

Species-specific Demands Trigger New R&D Areas in Animal Healthcare Market, Notices a New FMI Study

Animal feed represents the most profitable product type segment, presenting multiple investment opportunities for animal healthcare market operators. Top selling potential of animal feed additives is attributed to a growing focus on disease outbreak prevention rather than on curing disease afflicted animals. Animal healthcare market in China and Japan is especially observing robust demand growth …

Species-specific Demands Trigger New R&D Areas in Animal Healthcare Market, Notices a New FMI Study Read More »

CPhI South East Asia rescheduled for 2021

CPhI South East Asia – organised by Informa Markets – has been rescheduled to May 18-20, 2021 to give the ASEAN pharma community more time to recover and to mitigate any global disruptions caused by COVID-19. The decision to reschedule the event to 2021 reflects changing attendee needs. By moving to spring next year, we …

CPhI South East Asia rescheduled for 2021 Read More »

Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service

Okapi Pharmacy, a wholly-owned subsidiary of Toppan Printing (Toppan) (TSE:7911), a global leader in communication, security, packaging, décor materials, and electronics solutions, has today announced the launch of Todokusuri EXPRESS, a service for delivering prescription medicines to patients through Todokusuri Yakkyoku, a pharmacy opened on July 1. Todokusuri EXPRESS responds to the needs of the …

Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service Read More »

Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service

Okapi Pharmacy, a wholly-owned subsidiary of Toppan Printing (Toppan) (TSE:7911), a global leader in communication, security, packaging, décor materials, and electronics solutions, has today announced the launch of Todokusuri EXPRESS, a service for delivering prescription medicines to patients through Todokusuri Yakkyoku, a pharmacy opened on July 1. Todokusuri EXPRESS responds to the needs of the …

Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service Read More »

Softbox announces the appointment of new global CFO

Softbox, a leading global innovator and provider of temperature control packaging systems and thermal covers for the life science and logistics industries, has announced the appointment of Charlie Nicholson as Softbox’s new Global CFO. Reporting directly to Kevin Valentine, CEO of Softbox, Charlie Nicholson joins the leadership team and is responsible for all financial and …

Softbox announces the appointment of new global CFO Read More »

Pharmapack Moves to May 2021

Pharmapack Europe (#pharmapackeu), organised by Informa Markets, moves to May 2021 (19-20) to provide attendees, exhibitors and the pharma packaging community the best season and format. The decision follows a careful review with key stakeholders, with the exhibition continuing at its usual location: Hall 7.2 at Paris Expo, Porte de Versailles. By announcing the rescheduling …

Pharmapack Moves to May 2021 Read More »

PCRS releases new guidance on diagnosis of respiratory conditions during COVID

The Primary Care Respiratory Society (PCRS) has issued a position statement and recommendations for clinicians on the diagnostic work up of patients presenting with respiratory symptoms while Covid-19 remains in active circulation. The recommendations bring together the cross-functional experience of PCRS members on the safest and most appropriate approach when evaluating patients presenting with respiratory …

PCRS releases new guidance on diagnosis of respiratory conditions during COVID Read More »

Impact Biomedical initiates Quantum Research Program to solve the Patent Cliff

SGX-listed Singapore eDevelopment Limited’s (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. (“Impact”), announced today the initiation of Quantum, their research program designed to solve the impending pharmaceutical patent cliff threat. Impact Biomedical’s transition to the Quantum research program comes on the heels of the completion of the research and development stage of its existing biodefense …

Impact Biomedical initiates Quantum Research Program to solve the Patent Cliff Read More »

CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched

CPhI Japan – organised by Informa Markets – announces that, following a detailed review with partners and key industry stakeholders and to ensure the health and safety of our community, the event will be postponed until April 14-16, 2021. The event organiser’s move to the new dates will provide more time for the market to …

CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched Read More »

DuPont Announces Research Collaboration with Rutgers University

DuPont Nutrition & Biosciences (DuPont) today announced a research collaboration in microbiome science with the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers University in New Jersey. The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation …

DuPont Announces Research Collaboration with Rutgers University Read More »

Cariflex to Double its Polyisoprene Latex Capacity at the Paulinia Facility in Brazil

Cariflex PTE. Ltd. (Cariflex) announced that it will be constructing a new large-scale polyisoprene latex plant at its Paulinia, Brazil, facility to meet the strong market demand from its medical and consumer product customers. Cariflex is excited to be making a sizeable investment in the growth of the polyisoprene latex business. Cariflex polyisoprene latex is …

Cariflex to Double its Polyisoprene Latex Capacity at the Paulinia Facility in Brazil Read More »

Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award

Adelaide, AUS – The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award at a global virtual awards ceremony overnight. This is the first Frost & Sullivan award for the company which has seen rapid growth in the APAC region over the past year. According …

Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award

Read More »

First New Drug Application for Dayvigo in Asia outside Japan

TOKYO: Eisai Co., Ltd. announced today that the new drug application for approval of its in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance, has been accepted by the Hong Kong Department of Health. This application is the …

First New Drug Application for Dayvigo in Asia outside Japan Read More »

Romaco Introduces New Robotic Microdosing Machine Specially Designed for Filling Potent and Cytostatic Medicines

The MicroRobot 50 microdosing machine is Romaco Macofar’s innovative high-tech solution for filling cytostatic powders into vials. Three anthropomorphic robots ensure reliable processes protected by an isolator. Romaco Macofar’s MicroRobot 50 is a robotic microdosing machine that is specially designed for filling potent and cytostatic medicines, for example for treating cancer and auto-immune diseases. The …

Romaco Introduces New Robotic Microdosing Machine Specially Designed for Filling Potent and Cytostatic Medicines Read More »

Sales record 2019 – Sanner achieves over 85 million euros

Sanner, international manufacturer of pharmaceutical primary packaging and medical technology products, has completed a highly successful business year 2019: with a total turnover of just over 85 million euros, the group even set a new record. Thanks to investments in new products and existing sites, Sanner is optimistic about the future despite the Corona crisis. …

Sales record 2019 – Sanner achieves over 85 million euros Read More »

CPhI Festival of Pharma to support and lead global pharma industry forward with new digital experience in 2020

Over recent weeks and months, CPhI Worldwide – organised by Informa Markets – has been in constant discussions with key industry stakeholders and partners to stay abreast of the challenges and complexities facing the different segments of the Pharma industry in the face of disruption due to COVID-19. This has included working closely with all …

CPhI Festival of Pharma to support and lead global pharma industry forward with new digital experience in 2020 Read More »